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Abstract: Extracorporeal shock wave lithotripsy (ESWL) is a non-surgical method that can be used to break 
stones in the urinary tract or kidney stones by focusing the shock wave from outside the body on the location 
of the stone. In its application, ESWL is classified as theranostics by applying the principles of medical 
physics in determining the location of kidney stones and biophysics in the therapeutic process. This study 
aimed to analyze the use of ESWL to treat kidney stones in Dr. Saiful Anwar Malang hospital. The ESWL 
machine analyzed was the ESWL PIEZOLITH 3000 Triple Focus, which used the Richard Wolf 
piezoelectric lithotripter, with serial number GA-A 175. This analysis was carried out by combining the 
results of the method of literature research, observation, and interview. Based on the results of the research, 
the therapy with the ESWL PIEZOLITH 3000 Triple Focus uses a shock wave generated by the piezoelectric 
effect of piezoelectric crystals that are arranged like a mosaic in a spherical cup and are then activated 
simultaneously by a pulse generator. During the observation from July 18, 2017 to July 27, 2017, the 
smallest dimension of the treated stone was 6 x 6 mm and the largest was 10 x 15 mm. The number of shock 
waves used is the same with an average of 4000. The power, frequency, and membrane pressure are adjusted 
with the patient's body condition. Various criteria and contraindications must be met to determine a 
candidate for a patient to gain satisfactory results. The therapy levels include the pre-therapy procedure, 
therapy implementation, and post-therapy. The success rate of therapy and the rate of retreatment are 
determined by the type of stone, the location of the stones, and the density of the stones.  
Keywords: theranostics, medical physics, biophysics, piezoelectric effect 
 
1. Introduction 
Current technological developments have different effects on different aspects of life, including health. This 
revolutionary change in healthcare was triggered by the discovery of various innovations in examination and treatment 
techniques. In urology, we know Extracorporeal Shock Wave Lithotripsy (ESWL) which can be used to treat kidney 
stones. Etymologically, ESWL consists of the words “extracorporeal” (from outside the body or above the skin), 
“shock wave”, and “lithotripsy” (litho which means stone and tripsy which means destroy). Therefore, ESWL can be 
interpreted as a non-surgical method that can break stones in the urinary tract by focusing shock waves from outside 
the body on the location of the stone.1 
Therapeutic methods using ESWL include early-stage or pre-therapy procedure,2 method of performing therapy, 
and post-therapy procedure. Kidney stone therapy with ESWL must be well prepared, as not all types of stones can be 
destroyed with this method. Therefore, size, location of the stones, kidney anatomy, patient's health, and 
contraindications must also be taken into consideration because these factors contribute to the success rate and 
retreatment rate of ESWL therapy.1 
In general, all lithotripsy machines consist of 4 main components. They are shock wave generator, focusing 
system, coupling mechanism, and imaging or localization unit.3 In this study, analysis of the use of ESWL to treat 
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kidney stones was performed on the ESWL PIEZOLITH 3000 Triple Focus using Richard Wolf's piezoelectric 
lithotripter with serial number GA-A 175.  
The piezoelectric lithotripter uses the piezoelectric effect on crystals. In a piezoelectric shock wave generator, 
dozens to thousands of piezoceramic are arranged on a disk, which conducts energy from whole ceramic elements to 
the therapeutic focus. Piezoelectric generators have a hemisphere that is attached to many piezoelectric crystals. When 
a high voltage with a high frequency flows through the piezoelectric crystal, there would be a reverse piezoelectric 
effect in the piezoelectric crystal. The piezoelectric crystal then generates stretching vibration and water molecules 
will vibrate to generate shock waves. The shock waves are focused on the focal point of the hemisphere where the 
calculi is located so that the calculi can be destroyed.3 
The piezoelectric shock wave generator is a type of direct focusing system (DFL = direct focusing lithotripsy). 
All ceramic elements are focused on the therapy focus. The stone will be fragmented by a combination of energy 
generated from a continuous discharge process. In order to increase the output energy without the need for a larger 
disk, the Wolf Piezolith 3000 has a double layer of piezoceramic elements. 
The piezoelectric lithotripter has the advantage of a small focal point with high peak pressure. In addition, the 
piezoelectric energy source has a single frequency, less noise, and little damage to the tissue around the target. 
However, the weak penetration ability and the high attenuation that occurred, lead to low therapy efficiency and high 
retreatment rates. The complex piezoelectric structure also requires high technical skills, so the piezoelectric 
lithotripter is less used compared to electrohydraulic and electromagnetic ones (apart from the reason for its lower 
effectiveness compared to other types of lithotripters). The large diameter of the disk which contains many 
piezoceramic elements also makes it difficult to combine with multifunctional machines.3 
The analysis of the use of ESWL PIEZOLITH 3000 Triple Focus for the treatment of kidney stones is intended to 
provide an overview of the application of medical physics and biophysics in kidney stone therapy with ESWL so that 
similar studies can be reproduced and developed in the future. With a detailed study and a keen understanding of the 
science involved in treating kidney stones with ESWL, it is hoped that kidney stone therapy with ESWL can be 
improved to be more efficient and produce satisfactory results. This study therefore explains the principles of medical 
and biophysical physics that are applied in kidney stone therapy using ESWL, therapy methods and results, and 
factors that influence the success rate of therapy and the rate of retreatment. 
2. Materials and methods 
The material used in this study focused on the ESWL PIEZOLITH 3000 Triple Focus for the therapy of kidney 
stones. This study was based on the results of the internship at Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang 
from July 17 to August 11, 2017. The analysis was carried out by combining the results of the literature study method, 
observation, and interview. Literature study was conducted before activity, during activity, and after internship 
activity. This method used books, journals on related topics, and a manual book of ESWL PIEZOLITH 3000 Triple 
Focus. Thereafter, the collected data and materials were used to make reports and then being compared with the 
results or data obtained during the internship. Observation had conducted during the internship. This activity was 
carried out through direct observation on the process of treating kidney stones using the ESWL PIEZOLITH 3000 
Triple Focus in Dr. Saiful Anwar, Malang. The recorded data sample was the sample of patient data from July 17, 
2017 to July 27, 2017 (excluding Saturdays and Sundays). The recorded data included the date of therapy, gender, 
age, stone size, number of shock waves, force, frequency, membrane pressure, and stone type. This data collection 
was known and had been approved by the parties concerned. In the meantime, interviews had been conducted by 
asking supervisor, field supervisors, therapy operators, and patients. All data obtained were then analyzed and 
compared with a literature study that was already carried out. During the internship, the study was limited to the use of 
the ESWL PIEZOLITH 3000 Triple Focus for kidney stone treatment procedures. 
3. Results and discussion 
3.1 General description of ESWL PIEZOLITH 3000 
The extracorporeal shock wave lithotripsy (ESWL) used at RSSA is the ESWL PIEZOLITH 3000 Triple Focus, 
which is produced by the Richard Wolf brand with the serial number GA-A 175. This type of ESWL uses a 
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piezoelectric lithotripter. PIEZOLITH consists of a device trolley, a compatible therapeutic source with an ultrasound 
locator, a separate ultrasound device, and an X-ray unit. Besides, there is an electrically operated treatment table that 
enables the patient to be positioned vertically and horizontally relative to the focus point of the therapy. PIEZOLITH 
3000 is intended to fragment urinary stones in the kidneys (renal pelvis and calyx) and the ureter (upper, middle, and 
lower ureter). PIEZOLITH 3000 is available in 3 versions, namely with LITHOARM, with a stand, and with an 
articulated arm. 
The locating systems in PIEZOLITH are arranged isocentrically, with the aim that there is no deviation between 
the target cross and the focus of the shock wave, even if the direction of the shock wave is changed. For ultrasound 
locator, a suitable locating system enables precise localization, which can be visualized sonographically. Its result is as 
good as permanent sonographic control during therapy. For this purpose, an ultrasound probe is placed into the 
therapeutic source and can be rotated or moved along its longitudinal axis. The use of USG is also required for real-
time monitoring during treatment. For X-ray locator, the therapeutic source is patented on a C-arm X-ray isocenter via 
a LITHOARM or laser-monitored stand, which enables X-ray localization by confocal setting of the piezo power 
source with the X-ray C-arm from the AP to oblique point of view approximately 30°. The thing to know is that X-ray 
cannot be used together with an articulated arm. 
The fluoroscopy mode used in the ESWL PIEZOLITH 3000 Triple Focus is Ziehm 8000. Fluoroscopy is used to 
expose patients to X-ray. The Ziehm 8000 offers three different fluoroscopy modes, namely continuous fluoroscopy, 
continuous pulse fluoroscopy, and single pulse fluoroscopy. 
During the use of ESWL for therapeutic purposes, functional and operational safety tests must be carried out by 
experts (at least every 12 months) to avoid incidents caused by the age of the device. Besides, the device's ability to 
break stones must be tested with a test stone. The density of the stone can be determined by HU (Hounsfield Unit). 
Stones with a density >1000 HU are usually difficult to break because the stone is hard. Uric acid stones can usually 
be treated with sodium bicarbonate. 
3.2 Piezoelectric Effect 
Piezoelectric comes from the Greek word piezo which means pressure and electric which means electricity. 
Piezoelectric is a material that generates an electric field when it is given mechanical stress and when an electric field 
is applied to it, mechanical deformations or changes in the material dimensions occurred. Piezoelectric was first 
discovered by Pierre Curie and Jacques Curie in 1880, and it was finally able to be applied to industrial tools in 1950. 
Thereafter, piezoelectricity is also used in various applications, such as medicine, aerospace, nuclear instruments, and 
on mobile pad touchscreen as pressure sensor. 
Piezoelectricity is defined as the ability of some crystals or certain other materials to generate an electrical voltage 
when subjected to pressure or expansion. Piezoelectric has reversible effects. They are the direct piezoelectric effect 
(generating electrical potential due to mechanical stress) and the converse piezoelectric effect (pressure is generated 
due to the application of electrical voltage which leads to dimensional changes). Piezoelectricity is a phenomenon 
when a force exerted on a segment of a material creates an electrical charge on the surface of the material segment, 
caused by the distribution of the electrical charge in the crystal cells. The values for the piezoelectric charge 
coefficient are in the range from 1 to 100 pC/N. 
The scientific basis for the process of generating shock waves from piezoelectrics is the spontaneous expansion of 
ceramic particles, which is caused by a high-voltage pulse that is given in a short time (short-term high-voltage pulse). 
This expansion of the ceramic material creates a pressure wave in the water that is able to generate shock waves in the 
focal point. The pressure that hits the piezoelectric then creates an electric field. As the electric field passes through 
the material, the polarized molecules will adapt to the electric field. And then, the induced dipole with the molecular 
or crystal structure of the material will be formed. The adjustment of the molecules will change the dimension of the 
material. This phenomenon is known as electrostriction (piezoelectric effect). 
The piezoelectric effect can be used in transducers that convert sound waves into electrical fields or vice versa. It 
is important to know that the amount of electric potential created is proportional to the amount of pressure applied. 
The greater the pressure applied, the greater the electric potential generated. When an AC voltage is given to the 
piezoelectric crystal, the piezoelectric material also moves back and forth that it can generate high-frequency sound 
waves or ultrasound (US). 
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In PIEZOLITH, the piezoelectric elements are arranged like a mosaic in a spherical cup, which is then activated 
simultaneously by a pulse generator. The spherical design with a wide active surface and a large aperture enables a 
precise focus zone with high sound pressure in its focus. 
The wide energy coupling area can reduce the energy density on the skin surface to relieve pain, especially when 
shallow penetration is required. The precise focus zone enables precise treatment and the best possible protection of 
the surrounding areas. The PIEZOLITH system also enables the use of single pulse and continuous pulse modes. The 
power of the shock wave used consists of 20 intensity levels that can be adjusted to the needs of the patient. 
3.3 Ultrasound Wave and Shock Wave 
Ultrasound (US) is a sonic vibration with a frequency of more than 20 kHz. Ultrasound is a type of mechanical 
wave.4 In biological substances, there are mostly only longitudinal waves. The ultrasonic frequencies used in medicine 
are in the range from 1 to 15 MHz.5 Medical devices that employ ultrasonic waves have a variety of functions, from 
non-invasive internal organ imaging to the therapy of muscle tissue using the mechanical and thermal effects of 
ultrasound on biological materials and for rheumatology. Besides, this technology is also used for non-invasive 
measurement of blood flow and blood pressure. 
Ultrasonic waves are not only limited to medical diagnosis,6 but it is also used for therapeutic purposes.7 For 
example, the low-frequency US waves (20 to 100 kHz), which are used to treat chronic sinusitis,8 dental,9 eye 
surgery,10 etc. Besides, high-intensity focused ultrasound (HIFU) technology can also be used to treat tumors that may 
develop into cancer,11 psoriasis,12 dermatological purposes,13 etc. Other uses include fragmentation and removal of 
biological tissue,14 activation of transplanted organs,15 biopsy,16 gynecology and obstetrics,17 pediatric anesthesia,18 
forensic testing,19 and sterilization of medical devices.20 
The effects caused by ultrasound include chemical effect, biological effect, mechanical effect, and thermal effect. 
The chemical effect caused by ultrasound can cause oxidation and hydrolysis of the polyester bonds. The biological 
effect caused by the ultrasound are usually a combination of other effects. In general, biological effects are divided 
into thermal and non-thermal mechanisms.21 For heat therapy, the principle is to use ultrasonic waves of a certain 
power or high intensity that can cause the material vibration in the tissue and then heat it. This heat creates the desired 
therapeutic effect.22 Local heating is usually used to warm blood vessels (causing them to dilate) or to cause tumor 
necrosis. The power used for this purpose usually does not exceed 5 𝑊/𝑐𝑚2 for penetration into the tissue.23 This 
biological effect later triggers the thermal effect. The mechanical effect of ultrasound can disintegrate some solid 
objects, such as kidney stones and gallstones. 
The characteristic value of ultrasonic waves can be traced by the ultrasonic wave equation. This equation depends 
on the distance a, the time t, the amplitude A, and ω, which is the angular frequency of the mechanical disturbance 
emitted by the vibration source. 
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Where As: elongation or oscillating particle distance of its rest position, ω: angular frequency, a: distance between the 
center of excitement and the site consideration.5 
The ultrasound intensity used for medical diagnosis varies between 10 and 50 m𝑊/𝑐𝑚2, while an intensity range 
of 1 to 3 𝑊/𝑐𝑚2 is used for therapies such as diathermy. Another use of ultrasound with an intensity range of 10 to 20 
𝑊/𝑐𝑚2 is for cavitation (ability to destroy molecules) used in lithotripsy or nebulization.24  
Another quantity to consider is the ultrasonic velocity passing through the medium. The particle velocity v in 
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Where 𝑣𝑚 = 𝐴𝜔 is the maximum instantaneous velocity.5 The velocity of ultrasound passing through the medium is 
influenced by the density and compressibility of the medium. The denser the medium is, the faster the velocity is. If 
the ultrasonic velocity in the medium is already known, the point of reflection depth corresponding to the resulting 
echo can be known with the time required for the echo to return is provided.25 In the human body, the ultrasound 
speed is between 1500 and 1600 m/s, while it is 3360 m/s when passing through the bone.26  
Shock waves are sound waves or pressure waves that propagate through the medium through alternating 
compression and decompression process of the medium. At the interface between the medium with different acoustic 
impedances, absorption, reflection, or refraction of the shock waves can occur. Shock waves can be produced by the 
sudden release of mechanical, electrical, chemical, or nuclear energy in a confined space. This is usually accompanied 
by sudden changes in the pressure, density, temperature, entropy, and velocity of the particles. Shock waves can 
propagate differently than ordinary sound waves.27 
The low-pressure shock waves generated by the generator are concentrated in one place where the kidney stones 
are located. Only at this focal point, the shock waves have enough pressure to destroy its target, so that is no part 
outside this focal point is damaged. Another important point is that, unlike ultrasound, shock waves do not transmit 
heat, so thermal damage to the kidneys from ESWL exposure is negligible.  
Shock waves have properties similar to conventional ultrasound. Ultrasound is characterized by an alternation 
between compression and stretching. Besides that, ultrasound also consists of a sine wave or series of pulses at a 
specific frequency. Meanwhile, shock waves are high energy wave that consists of a single high-pressure peak with a 
steep start and a gradual decay.27 
Thus, it can be seen that the shock wave frequency range is wider than that of ultrasound. Ultrasound has a 
characteristic frequency, while a shock wave is made up of many frequencies called the shock wave frequency 
spectrum. The advantage of using shock waves for various medical applications is that the shock wave attenuation 
when passing through the human body is less compared to ultrasound. This is because high frequencies are more 
attenuated than low frequencies. Sometimes shock waves are also intended for lithotripter pulses, which are non-linear 
high-pressure pulses with very short rise times and a wide frequency spectrum.27 
It should be known that the velocity of every mechanical wave (such as audio sonic or ultrasound) increases as the 
compressibility of the medium decreases. Therefore, the velocity increases as the density of the medium increases. In 
the meantime, the density of the medium can also change as the waves move through the medium. Similarly, the 
propagation of shock waves causes the medium to become denser. 
When a wave passes through the medium, energy is lost through friction. The absorption of this energy can lead to 
a decrease in the pressure amplitude. The pressure amplitude decreases exponentially as the depth of the tissue is 
traversed. The penetration into the tissue also depends on the frequency of the wave.27 
The shock wave peak pressure attenuation in water ranges from 10 to 20% over a distance of 100 mm. As 
explained earlier, the velocity of the shock wave in water depends on the pressure. The higher the pressure, the higher 
the speed. The energy attenuation caused by the shock wave through the lithotripter membrane of the water cushion is 
up to 20%. However, if the voltage of the shock wave generator is increased, this can be overcome.27 
In general, acoustic waves can cause a variety of effects when propagating through the medium. Common 
examples are heating, cavitation, compression, stretching, reflection, and turbulence. Heating occurs due to the 
absorption of acoustic energy, which is then converted into heat in the material or tissue. This effect depends on the 
physical properties of the material, the intensity of the acoustic radiation, the duration, and the frequency. Dynamic 
agitation and shear stress from the waves can affect the structure of properties. Acoustic cavitation can create free 
radicals. In addition, sound waves can cause rapid compression and expansion of tissue. Reflection occurs when the 
wave hits the interface (where there is a difference in acoustic impedance). If the difference in acoustic impedance 
between the two media at the interface is large enough, the amount of energy reflected is also large. Turbulence or 
"acoustic streaming" can occur at the interface between liquid and solid or between gas and solid.27 
When the shock wave hits a stone with a different acoustic impedance to water, some of the shock wave will be 
reflected. The shock waves that go through the stone are reflected in the second acoustic difference between the rock 
and the surrounding liquid. It is this reflection of the shock wave that creates stone fragmentation. Stone fragmentation 
is obtained through erosion and grinding mechanisms. Since there is no difference in acoustic impedance between the 
water and the surrounding soft tissue, the shock wave is not reflected. It makes shock wave will be transmitted so that 
there is no fragmentation effect on the surrounding soft tissue. Shock wave interactions with stone usually involve a 
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combination of different mechanisms, namely the Hopkinson effect, cavitation, quasi-static crushing, and dynamic 
fatigue. The resulting traumatic effect is frequency-dependent. Low-frequency components can cause larger amplitude 
displacement compared to the high-frequency range. The effective component for ESWL therapy is over 200 kHz 
meanwhile the ineffective component is between 20 and 200 kHz. 
Cavitation is known to be the main mechanism of tissue damage during ESWL.28 Although it is important in 
fragmenting stones, the effect of cavitation is also identified as the main cause of the adverse effects on tissues caused 
by shock waves. To minimize the damage caused by cavitation, the pressure (negative component) on the shock wave 
path must be made small. 
The image generated in ultrasonic mode B shows that cavitation bubbles arise during the ESWL, which is resulted 
from the negative pressure of the shock wave. The bubble formation was also noted during ESWL treatment of the 
renal parenchyma. Bubble activity in tissues does not usually appear until after continuous treatment with hundreds of 
shock waves.27 
The tensile component of the shock wave that is centered in the direction of the focal area can exceed the threshold 
for cavitation in urine, blood, or tissue. However, cavitation in tissues is different from that in blood or urine. The 
occurrence of cavitation can trigger the formation of bubbles. When the bubbles are deflated, the secondary shock 
waves and high-velocity microfluidics are created. The microjet effect can lead to tissue damage, especially in thin-
walled blood vessels. This can cause bleeding/hematuria, which occurs temporarily within 1-2 days. The size of the 
microbubbles in commercially available ultrasound contrast materials is approximately 1 to 10 micrometers. With 
lithotripter pressure, cavitation can be produced in vessels with a core diameter of 20 nm. Not only can shock waves 
cause cavitation and cause bubbles to form, but they can also excite nerves. Even under certain circumstances, shock 
waves can increase the permeability of the cell membrane so that large molecules can become trapped in the cell 
without the cell dying. 
3.4 Therapeutic procedure with ESWL PIEZOLITH 3000 
3.4.1 Procedure before therapy 
Before starting therapy with ESWL, patients must be consulted first. During the initial consultation, a medical 
history is reviewed along with the patient's medical records. Additionally, it is very important to tell your doctor about 
any medications, supplements, or herbs that you are taking. This is due to the types of antiplatelet drugs like aspirin, 
ibuprofen, Motrin, Advil, Alka-Selters, Vitamin E, Ticlid, Coumadin, Lovenox, Celebrex, Voltaren, Vioxx, Plavix, 
and various other drugs for arthritis or blood thinners like warfarin can affect the blood's ability to clot and cause 
bleeding. These drugs should be avoided for a week before the therapy date. This procedure must be done to obtain 
the last urine culture is free from these types of drugs before the therapeutic procedure. It is important to remember 
not to stop taking medication without asking for approval from the prescribing doctor. 
After that, the patients should take medical urine test to determine kidney function, stone type, and physical 
fitness. The most important test is X-rays or USG to determine the location of the stone and its possible type. 
Preoperative tests that may be required include physical examination, electrocardiogram (EKG), complete blood count 
(CBC), blood coagulation profile (PT/PTT), comprehensive metabolic panel (blood chemistry profile), and urine 
analysis. 
Good candidates for ESWL are: 
▪ Stone size between 1-3 cm or 5-10 mm with bothersome symptoms 
▪ Types of stones that contain calcium or uric acid are more brittle and easily fragmented 
▪ Location of the stones in the kidney or ureter proximal and medial 
▪ The lack of kidney obstruction (no obstruction distal or at the bottom of the duct) by stones and 
kidney function is still good 
▪ The patient's state of health is eligible 
▪ No bleeding disorders. 
▪ Not pregnant as this therapy also uses X-rays 
These criteria are critical to the success of ESWL. This is because this method cannot destroy all types of stone. 
Besides, the size, position of the stone, kidney anatomy, and the patient's state of health also affect. These criteria can 
be met by considering several things, one of which is a contraindication to performing an ESWL. Such 
contraindications include: 
▪ Pregnancy or suspected pregnancy 
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▪ Coagulopathy (bleeding disorder) or so-called coagulation abnormality (usually indicated by abnormal 
prothrombin time, partial thromboplastin time, or bleeding time) or for those who have recently received 
anticoagulants (including aspirin). 
▪ Uncontrolled high blood pressure 
▪ Distal urinary tract obstruction 
▪ The dysfunctional kidneys 
▪ The presence of the active infection 
▪ Arterial calcification or vascular aneurysm where the shock wave generated by the lithotripter passes 
through. 
▪ Anatomical conditions that obscure or prevent the device from focusing on the target stone location, e.g. 
severe obesity or excessive spinal curvature. 
▪ Immobile asymptomatic diverticulum stones or complicated staghorn calculi in the renal calyx. 
Therefore, the risks and benefits of ESWL need to be carefully considered. Other things that need to be warned 
are: 
▪ Bilateral stones: Treatment of bilateral stones should not be done in one treatment session as this can lead to 
bilateral kidney injury or complete obstruction of the urinary system with stone fragments. Therefore, this 
case must be treated with different therapy sessions for each side. 
▪ Interfaces of air-filled shock wave paths: Shock waves should not be applied to air-filled areas of the body, 
e.g. on the intestines or the lungs. The shock wave quickly dispersed across the air-filled interface, which can 
lead to bleeding and other adverse effects. 
▪ Arrhythmias during treatment: You can reduce the intensity of the shock waves and the repetition rate. In 
general, patients with a history of symptoms of this disease should have an ESWL-monitored EKG. 
In addition, things that need to be considered for treatment are: 
▪ Kidney Injury: To reduce the risk of injury to the kidney and surrounding tissues, it is recommended: 
a. The number of shock waves generated during treatment must be minimized. 
b. Retreatment for the kidney or the same anatomical part should be carried out at least one month after the 
first treatment. 
c. Any kidney or anatomical part should be restricted in the number of therapy sessions. The total number 
of therapy sessions allowed is three. 
d. The use of fluoroscopy must be done by minimizing the exposure that the patient receives during the 
therapeutic procedure. 
e. Electromagnetic interference. 
If the patient is determined to be a suitable candidate for the procedure, the patient should meet with the patient 
service surgery coordinator to schedule an appointment for the procedure to be performed. Then the patient receives 
several forms. The forms include the ESWL report form, the ESWL firing form, and the ESWL status. The ESWL 
report form contains patient data, treating physicians, stone positions, etc. The ESWL firing form contains patient 
data, the treating physician, the number of shock waves and therapy sessions, and information about the shock wave 
firing. The ESWL status contains the patient's data as well as the required clinical data. This ESWL status is 
mandatory for the patient. This ESWL status is usually given to patients who are undergoing therapy for the first time. 
3.4.2 Therapeutic implementation procedures 
After reaching the established therapy plan, the patient is given medication for anesthesia and antibiotics to 
prevent infection. The type of anesthesia is general anesthesia. Kaltrofen is often used for this. Patients usually do not 
experience pain. Sometimes the patient can stay awake during the procedure and even follow the progress of the 
procedure on the ultrasound or X-ray monitor. During therapy, the patient is given hospital clothing and is asked to lie 
down on the operating table/on a pillow during the ESWL procedure. The patient is then taken to the recovery room 
for observation for two hours before being allowed to go home. However, some patients may need to be hospitalized 
for a day or two if there are other health issues. Therefore, the patient reports to the hospital or clinic on the day of the 
ESWL procedure and may be able to leave the hospital on the same day. The ESWL procedure can also be carried out 
on a basic outpatient. 
Treatment steps with an ultrasound localizer and an articulated arm: 
▪ Move the treatment table to the center 
Setyawan   J. Med. Phys. Biop. 8 (1), August 2021 
 8 
▪ Set the ultrasound probe to 0° or 90° 
▪ For high penetration: low membrane pressure and the ultrasound probe is withdrawn. 
▪ For low penetration: high membrane pressure and extended ultrasonic probe. 
▪ Stabilize the patient's position on the treatment table 
▪ Apply gel evenly and arrange it so that no air bubbles form on the coupling membrane and the patient. 
▪ Place the therapy source relative to the patient so that the therapeutic area is visible on the ultrasound 
monitor. To do this, the articulated arm or individual joints must be moved. 
▪ Set the required penetration depth of the therapeutic focus with the membrane pressure button. The inflation 
of the coupling membrane determines the depth of penetration of the therapeutic focus. 
▪ Move the operating table horizontally and vertically until the therapy field is symmetrical to the target cross. 
The ultrasound probe must be moved radially to ensure that the therapy field and the target cross are 
completely aligned. 
▪ If the ultrasound image is poor, more gel must be applied to both the coupling membrane and the patient. If 
the patient moves, shock wave therapy should be stopped and repositioned until the therapy field is exactly 
symmetrical to the target cross again. 
▪ Carry out another ultrasound localization after at least 1000 shock waves and reposition the treatment table if 
necessary 
Important informations for therapy are: 
▪ Good ultrasound images indicate good transmission of shock wave energy, so there is a high probability that 
the treatment will be successful. 
▪ The ultrasound probe must be rotated to obtain the optimal angle of view. 
▪ For localizers, the ultrasound probe can be moved axially in the direction of the therapeutic focus to achieve 
a direct coupling of the ultrasound probe with the patient's skin by using the coupling membrane. This is 
done to prevent multiple reflections so that an optimal ultrasound image can be obtained. 
▪ To avoid loss of energy during shock wave therapy, the ultrasound probe should be pulled as far as possible. 
▪ The penetration depth is applied with a therapeutic focus distance of 152 mm in front of the shock wave rim. 
If it is possible to apply a small amount of compression to the patient's body, the depth of penetration can be 
increased up to 165 mm (e.g. for adipose patients). Treatment is gradual, especially if there are several 
stones. For example, for every 1000 shock waves that able to destroy stone up to 2.95 m-3mm. 
3.4.3 Patient Data Sample 
The recorded patient data were obtained from July 17, 2017 to July 27, 2017 (except Saturdays and Sundays). 





Power Frequency Membrane 
Pressure 
Stone Type 
1. 18 July 
2017 
M 53 10 4000 18 F1-1 - Right-UPJ  
2. 18 July 
2017 
F 56 6 4000 17 F1-1 6-7 Upper pole 
sin 
3 19 July 
2017 
M 36 13 4000 18 F1-1 8-9 Ren sin 
4. 20 July 
2017 
M  42 10x15 4000 16,18 F1-1 9 Ren dex 
5. 20 July 
2017 
F 56 10 x 15 4000 18 F1-1 7-8 Lower ren 
dex pole 
6. 20 July 
2017 
F 54 10 4000 17 F1-1 8 Lower ren 
sin pole 
7. 20 July 
2017 
M 43 13 4000 17 F1-1 6-7 Lower buli 
pole dex 
8. 20 July 
2017 
M  39 - 4000 17 F1-1 8-9 Buli 
multiple 
sin 
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9. 20 July 
2017 
F  50 10 4000 14-18 F1-1, F1-2 7 Lower buli 
pole sin 
10. 21 July 
2017 
F  59 15 4000 18 F1-1, F2-1 6-7 Pyelum 
dex 
11. 21 July 
2017 
M  44 - 4000 17-18 F1-1 5-7 Pole tjal 
sin 
12. 21 July 
2017 
M  55 - 4000 16-18 F1-1 5-7 Lower pole 
dex 
13. 25 July 
2017 
F  - 8 4000 18 F1-1 5 Lower pole 
sin 
14. 25 July 
2017 
M  78 8 4000 18 F1-1 7-8 Middle 
pole sin 
15. 25 July 
2017 
M  - - 4000 17 F1-1 8-9 Lower pole 
16. 27 July 
2017 
M 66 12 4000 17-18 F1-1 6-8 Pyelum 
dex 
17. 27 July 
2017 
M  41 13 4000 18 F1-1 7-8 Lower dex 
pole 
18. 27 July 
2017 
F 28 6 x 6 4000 17 F1-1,F1-2 4-5 Ureter 
prox dex 
 
Based on these data, it can be seen that the number of shock waves used is the same, i.e. 4000 in total. This 
number is considered to be an ideal number because if it is less it will reduce the effectiveness of the treatment, while 
if it is excessive it will cause adverse effects on the kidneys, such as hematuria. The membrane pressure used also 
varies because it is adjusted to the patient's body shape (adipose patients should be treated with high membrane 
pressure) and the patient's endurance. If the patient is in pain, the membrane pressure should be reduced. The same 
applies to the use of frequency and power. 
3.4.4 After therapy 
After therapy, patients can go home immediately unless they have not been approved by the doctor, as the patient's 
condition requires close observation. Patients can have normal activities for 24 hours after therapy. After returning 
home, patients should have adequate rest for a few days after therapy. Besides, patients are recommended to consume 
more water for several weeks to help the kidneys and make it easier to remove the kidney stone fragments. Stone 
fragments can pass several days while urinating and last up to 12 weeks. Most patients will excrete urine mixed with 
blood for 1-2 days. 
A few weeks after the ESWL treatment, the urologist will do an X-ray to see if the stone has broken into small 
pieces and if those small pieces have passed through the kidney. If the stone breaks into small fragments, but the 
fragments are not visible, a repeated x-ray is taken after a few weeks. If the stone is not fragmented, the urologist may 
recommend further treatment. In many cases, subsequent ESWL treatment may not work if the stone is not 
fragmented in the first session of ESWL treatment. In this situation, other treatments such as ureteroscopy or 
percutaneous nephrolithotomy may be recommended. 
Although ESWL is a relatively safe treatment, it is important to be aware of the possibility of side effects. Possible 
adverse effects when using ESWL are: 
▪ Common (>20% of patients): hematuria, pain/renal colic, reddening of the skin where the shock wave was 
targeted 
▪ Occasionally occurs (1-20% of patients): urinary tract infection, urinary obstruction/steinstrasse, bruising on 
the skin where the shock wave was targeted, fever (>38°C), nausea or vomiting 




Setyawan   J. Med. Phys. Biop. 8 (1), August 2021 
 10 
4. Conclusion 
Based on this study, it can be concluded that Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-surgical 
method to break the stones in the urinary tract or kidney stones by concentrating the shock wave on the position of the 
stone from outside the body. RSSA uses ESWL PIEZOLITH 3000 Triple Focus (with piezoelectric lithotripter) from 
Richard Wolf brand edition with a number GA-A series 175. The therapy success rate and the retreatment rate are 
determined by type of stone, stone location, and stone density. The smallest stone that was treated in the period from 
July 18, 2017 until July 27, 2017 (except Saturdays and Sundays) was 6x6 mm in diameter and the largest was 10x15 
mm. The number of shock waves used was 4000. The power, frequency, and pressure membrane adjusted to the 
patient's body condition. To gain satisfactory results from therapy with ESWL, several criteria and contraindications 
must be fulfilled to determine the patient candidate. Therapy phases include procedure before therapy, performing 
therapy, and post-therapy. Besides, it is necessary to identify the possible side effects of therapy by doing observation 
after therapy. 
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